000739.SZ
000739.SZ
CNE000000Q45
APELOA PHARMA.
Loading chart...

Company Profile

Apeloa Pharmaceutical Co.,Ltd provides raw materials various pharmaceutical factories in the People's Republic of China and internationally. The company operates through API, CDMO, and Pharmaceutical segments. It offers API intermediates business, which includes cephalosporin, penicillin, psychotropic, cardiovascular and cerebrovascular, and veterinary API intermediates series; innovative drug R&D and production services CDMO include R&D services, commercial human drug projects, commercial veterinary drug projects and other commercial projects; pharmaceutical business includes anti-infective, cardiovascular, psychotropic, hepatobiliary and anti-tumor categories. The company also provides technology platforms, such as flow chemistry, synthetic biology and biocatalysis, crystallization and particle engineering, peptide, high potency compound, conjugate library service, oligonucleotide synthesis, and preparation and purification; and controlled-release formulation development, taste masking technology, and particle flow simulation. In addition, it exports its products under the Tianliwei, Baishixin, Li'an, Jutai, and other brands. Apeloa Pharmaceutical Co.,Ltd was founded in 1989 and is based in Dongyang, the People's Republic of China.

Related stocks

000661.SZ
000661.SZ • China
CCHN
71.9 CNY
4.39B USD 1Y -44.4%
600079.SS
600079.SS • China
HUMANWELL HEALTHCARE (GROUP) CO
19.23 CNY
4.7B USD 1Y -10.1%
600521.SS
600521.SS • China
ZHEJIANG HUAHAI PHARMACEUTICAL
17.45 CNY
3.91B USD 1Y -16.9%
000513.SZ
000513.SZ • China
LIVZON GROUP
30.5 CNY
4.05B USD 1Y -21.4%
002603.SZ
002603.SZ • China
YILING
15.53 CNY
3.88B USD 1Y -4.1%
600329.SS
600329.SS • China
TIANJIN PHARMACEUTICAL DA REN T
35.8 CNY
4.13B USD 1Y -17.6%
000423.SZ
000423.SZ • China
DEEJ
46.68 CNY
4.47B USD 1Y -1.3%
600535.SS
600535.SS • China
TASLY PHARMACEUTICAL GROUP CO L
14.2 CNY
3.17B USD 1Y -10.3%

Key Metrics & Overview

Detailed metrics & financial data of the company

Company Profile
5 Metrics

🛡️ Risk & Structural Analysis

Multi-Factor Risk Model & Market Data

7/7 Very High
5Y Volatility
40.2% p.a.
Max Drawdown (5Y)
-73.4%
Sharpe Ratio (5Y)
-0.24
Beta Factor
0.26
Size Class
Large Cap
Notes & Warnings
Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
Exemplary balance sheet strength: Very solid ratio of equity to debt.
🔴 Low analyst coverage – higher uncertainty in growth estimates & projections
Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (40.2% p.a.).
Historical Stress Test: Maximum peak-to-trough drawdown of -73.4% in the extended horizon.
ende